Lakewood-Amedex (NASDAQ: LABT) awards 33,784 director warrants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lakewood-Amedex Biotherapeutics Inc. director Tucker Joseph Edward received a grant of warrants to acquire 33,784 shares of Common Stock. The warrants carry an exercise price of $10.00 per share and were awarded as a grant/award acquisition, not an open-market purchase.
The warrants vest in four equal tranches of 8,446 warrants on October 24, 2026, April 24, 2027, October 24, 2027, and April 24, 2028, and expire on April 23, 2036. Following this grant, 33,784 derivative securities of this type are reported as directly held.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Tucker Joseph Edward
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Warrant to acquire Common Stock | 33,784 | $0.00 | -- |
Holdings After Transaction:
Warrant to acquire Common Stock — 33,784 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Warrants granted: 33,784 warrants
Exercise price: $10.00 per share
Underlying shares: 33,784 shares
+5 more
8 metrics
Warrants granted
33,784 warrants
Grant to director dated April 24, 2026
Exercise price
$10.00 per share
Exercise price for Common Stock under warrants
Underlying shares
33,784 shares
Common Stock underlying granted warrants
Post-transaction derivative holdings
33,784 derivative securities
Warrants held directly after grant
Vesting tranche size
8,446 warrants
Each of four vesting dates from 2026 to 2028
First vesting date
October 24, 2026
First 8,446 warrants vest
Final vesting date
April 24, 2028
Last 8,446 warrants vest
Expiration date
April 23, 2036
Warrants expire if unexercised
Key Terms
Warrant to acquire Common Stock, exercise price, expiration date, vest, +1 more
5 terms
Warrant to acquire Common Stock financial
"security_title: Warrant to acquire Common Stock"
exercise price financial
"conversion_or_exercise_price: 10.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-04-23T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest financial
"The warrants vest in four equal tranches of 8,446 warrants each"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
derivative securities financial
"derivativeTransactionCount: 1"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
What did the Lakewood-Amedex (LABT) director report in this Form 4?
The Form 4 reports that director Tucker Joseph Edward received a grant of warrants to acquire 33,784 shares of Common Stock at an exercise price of $10.00 per share, structured as a compensation-related award rather than an open-market stock purchase.
What is the exercise price and term of the LABT director warrants?
The warrants have an exercise price of $10.00 per share and an expiration date of April 23, 2036. This means the director may choose to exercise vested portions any time before expiration, paying $10.00 per share to acquire the underlying Common Stock.
How do the LABT director warrants vest over time?
The warrants vest in four equal tranches of 8,446 warrants each. Vesting occurs on October 24, 2026, April 24, 2027, October 24, 2027, and April 24, 2028, gradually increasing the director’s exercisable rights rather than making the full amount immediately exercisable.
Is this LABT Form 4 a stock purchase or a compensation grant?
This filing reflects a grant or award acquisition of derivative securities, coded as “A” for a grant/award, rather than an open-market purchase. The director did not buy shares on the market; instead, he received warrants that may later be exercised to purchase stock.
How many LABT derivative securities does the director hold after this transaction?
After this warrant grant, the Form 4 reports that the director holds 33,784 derivative securities of this type directly. These represent warrants that, once vested and exercised at the $10.00 exercise price, could result in ownership of an equivalent number of Common Stock shares.